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Abstract: Hereditary Haemorrhagic Telangiectasia (HHT), or Osler-Weber-Rendu syndrome is an uncommon autosomal dominant 
multi-organ condition of vascular dysplasias. We describe a 19 year old Indian female who presented with cerebral abscess secondary 
to paradoxical emboli from pulmonary arteriovenous malformations (PAVMs) associated with HHT. Cerebral, pulmonary, hepatic and 
gastrointestinal involvement can be life-threatening and it is important to have lifelong follow-ups on these patients.
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Introduction
The typical patient with HHT has clinical features 
of recurrent epistaxis, mucocutaneous telangiectases 
and  gastrointestinal  bleeding.1  Besides  involving 
post capillary venules that result in mucocutaneous 
telangiectases, HHT is associated with the formation 
of arteriovenous malfomations (AVMs) in the lungs, 
liver and brain. HHT has a prevalence rate that is 
as high as 1 in 10,000 in some parts of the world.2 
To make a definite diagnosis according to Curacao 
criteria, three out of four clinical features are to be 
present.3,4 These include spontaneous, recurrent nose 
bleeds, telangiectases at typical sites, visceral AVMs 
and a first degree relative with known HHT. It is a dis-
ease with variable penetrance that has a wide range of 
clinical presentations.
case Report
A 19 year old Indian female with no past medical 
history of note was admitted for complaint of severe 
headache associated with fever for 5 days’ duration. 
On physical examination, she was alert and orientated, 
with a fever of 39 °C . Her neck was supple but there 
was a right sided paraparesis of power 4/5 with upgo-
ing plantar reflex. Computed tomography (CT) (Fig. 1) 
and magnetic resonance imaging (MRI) (Fig. 2) of the 
brain revealed a 2 cm rim-enhancing space occupy-
ing lesion in the left thalamus with significant midline 
shift. The patient underwent a stereostatic biopsy of 
the mass and insertion of an external ventricular drain 
to  relieve  the  raised  intracranial  pressure.  Pus  was 
removed and it showed Gram positive cocci which was 
later identified as streptococcus sp. She was treated 
with  6  weeks  of  intravenous  ceftriaxone  followed 
by another 6 weeks of oral amoxicillin-clavulanate. 
The cerebral abscess resolved with treatment and the 
side of her body over the period of 3 months.
Various investigations were performed to determine 
the source of the cerebral abscess. Dental review was 
normal,  2-dimensional  trans-thoracic  echocardiog-
raphy did not show any infective endocarditis and 
otolaryngologist assessment was normal. While recov-
ering in the general ward, the patient had an episode 
of oxygen desaturation. A CT pulmonary angiogram 
was done (Fig. 3) to look for pulmonary embolism 
which was absent. Instead, the scan revealed multi-
ple PAVMs in both lungs. It was postulated that the 
PAVMs  allow  right-to-left  shunting  of  paradoxical 
emboli, resulting in the cerebral abscess.
On further questioning, the patient gave a history 
of  recurrent  spontaneous  epistaxis  since  the  age 
of ten. On close examination of the patient, a few 
scattered  telangiectases  were  seen  on  the  tongue 
and palate. Although there was no positive family 
  history, she fulfilled the criteria for the diagnosis 
of HHT.3
Figure 1. shows a 2.5 cm vague hyperdense rim-enhancing lesion 
(arrow) in the left thalamus with minimal mass-effect on 3rd ventricle.
Figure 2. MRI T2 image (2 days later) shows the same rim-enhancing 
lesion in left thalamus with increased mass effect.
patient  gradually regained full strength of the right Neurologic Manifestation associated with HHT
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Further investigations were performed to exclude 
AVMs in other sites of the body. MRI of the brain 
did not reveal any AVMs. CT liver did not reveal any 
AVMs. Transcatheter embolisation of the PAVMs was 
performed on 2 separate occasions. Left pulmonary 
angiogram (Fig. 4) showed 2 lower lobe PAVMs about 
1 cm in diameter and multiple embolic coils inserted 
successfully.  Right  pulmonary  angiogram  revealed 
4 PAVMs about 1 cm in diameter and embolisation 
of 3 lesions were done. One PAVM was inaccessible. 
She was followed up yearly to screen for new devel-
opment of PAVMs and AVMs from other sites.
Discussion
This case illustrates neurological symptoms as the 
first prominent manifestations of PAVMs and heredi-
tary haemorrhagic telangiectasia. The patient had no 
family history that would have prompted early screen-
ing for characteristic features of HHT and its visceral 
involvement. Although her epistaxis during her early 
teens were spontaneous and recurrent, there was no 
other prominent oral mucosa telangiectases to arouse 
any suspicion of HHT.
The incidence of cerebral AVMs and PAVMs were 
estimated to be 10%–15% and 11%–30%   respectively; 
PAVMs  are  mainly  asymptomatic  (25%–58%)  or 
present more commonly with respiratory symptoms 
than embolic phenomenon.5 The incidence of embo-
lic phenomenon in PAVMs was low, about 0%–25% 
have cerebral abscess and 11%–55% have transient 
ischemic attack or stroke.5 Consequently, neurologi-
cal symptoms are not common in patients with HHT, 
they consist of headache, transient ischemic attack, 
stroke, seizure, intracranial bleed and brain abscess. 
PAVMs  contribute  to  two  thirds  of  HHT-related 
  neurological symptoms while in the remaining one 
third, cerebral and spinal AVMs are responsible.6 Usu-
ally, the pulmonary capillaries filter effectively any 
thrombotic and septic emboli that enter the right side 
of the heart and prevent their entry into the systemic 
circulation. The presence of PAVMs allows shunting 
of these emboli, resulting in embolic manifestation in 
the brain, as seen in our patient.
HHT is an autosomal dominant disorder. Muta-
tions involving at least two genes were recognized so 
far: endoglin on chromosome 9 and activin receptor-
like kinase 1 on chromosome 12.5
Large AVMs  larger  than  1  cm  in  diameter  can 
cause shunting of blood. These occur commonly in 
the lung, but the brain, liver and gastrointestinal tract 
can also be involved. When occurring in the liver, it 
can result in portal hypertension, high-output heart 
failure  and  biliary  disease.7  In  the  gastrointestinal 
Figure 3. shows a focal nodular appearance of pulmonary vessels (arrow), 
representing one of the arteriovenous malfomations in the right lung.
Figure 4. Transcather embolisation with a metallic coil (black arrow) into 
a pAVM (white arrow) located in the right lung.Teo and Kor
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tract, recurrent bleeding can occur, especially after 
the age of 30.5
Our patient had HHT with a severe neurological 
complication but fortunately, she recovered with no 
residual neurological deficit. She did not have any 
cerebral or hepatic AVMs.
It was only in recent time that transcatheter embo-
lisation of PAVMs replaces surgical resection as the 
treatment of choice. The procedure involves the place-
ment of a metallic coil or balloon to occlude the feed-
ing vessels to PAVMs wth thrombus. It is   effective 
for reducing right-to-left blood shunting, improving 
hypoxemia and increasing exercise capacity.8 It may 
decrease  neurological  complications.  Transcatheter 
embolisation of PAVMs is considered safe, especially 
in  experienced  hands.  The  success  rate  has  been 
reported to be over 98% in cumulative series, with 
no report of mortality related to procedure.9   Pleurisy, 
paradoxical embolism and balloon deflation are some 
possible  complications.  Currently,  transcatheter 
embolisation is recommended for PAVMs with feed-
ing arteries greater than 3 mm in diameter.10 Surgical 
resection is indicated for patients who had a persis-
tent right-to-left shunt following embolisation of all 
  significant PAVMs. Lung transplant is also consid-
ered feasible in patients with diffuse disease.
Pulmonary  angiography  is  considered  the  gold 
standard in detection of PAVMs. But three other non-
invasive  methods  are  currently  available  to  detect 
PAVMs:
1. Radiography—chest radiograph or CT thorax
2. Detection of hypoxemia by pulse oximetry or arte-
rial blood gas
3. Detection of right to left shunt—100% inspired 
oxygen breathing method or contrast echocardiog-
raphy or radionuclide scanning
In a group of 105 patients with HHT, Cottin and 
colleagues11 did a comparison of the accuracy of a 
group  of  non-invasive  methods  to  detect  PAVMs 
against  CT  thorax  and/or  pulmonary  angiography. 
They recommended a screening algorithm that uses 
chest radiograph and contrast echocardiography, fol-
lowed by CT thorax if either test is positive. Screening 
directly by CT thorax is also an effective alternative.
Our  patient  had  been  followed-up  over  the  last 
few years with regular pulse oximetry monitoring and 
serial CT thorax scans. These had been normal so far 
and the follow-up is intended to be lifelong. Repeated 
screening tests for brain and liver AVMs are not rec-
ommended as there is no evidence that they increase 
in size over time.
Besides  screening  for  AVMS  in  the  various 
organs,  management  of  HHT  also  include  treating 
the   complications that may arise during the patient’s 
lifetime. Telangiectases, if comestically undesirable, 
can be treated with topical agents or laser ablation. 
  Significant or recurrent epistaxis can be treated with 
cauterization,  laser  ablation,  septal  dermatoplasty, 
course of estrogen or transcather embolisation of arter-
ies feeding nasal mucosa. Bleeding in the gastrointes-
tinal tract can be treated by endoscopic heater probes 
or laser. Patient education is essential. The patient 
was told of the need for antibiotic prophylaxis prior 
to any dental or surgical procedure. Besides screening 
the rest of her family members for this condition, we 
also provided genetic counseling to the patient as she 
is of child-bearing age.
conclusion
This is an interesting case of brain abscess of which fur-
ther investigations led to a diagnosis of a rare systemic 
condition of HHT and subsequent prevention of further 
life threatening complications. It serves to remind us 
the need to be thorough in our history taking and phys-
ical examination when seeing a patient. In addition, 
the case also emphasizes the importance of   lifelong 
follow-ups  of  systemic  conditions  that  may  have 
unpredictable clinical outcome and complications.
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